financetom
Business
financetom
/
Business
/
Why Sezzle (SEZL) Shares Are Trading Lower
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Sezzle (SEZL) Shares Are Trading Lower
Jul 11, 2024 8:40 AM

Sezzle Inc ( SEZL ) shares are trading lower by 1.3% to $80.90 during Thursday’s session after the company announced a proposed resale of up to 3,414,736 shares of common stock by selling stockholders.

The resale by the selling stockholders is not being underwritten by any investment bank. The company says it will not receive any of the proceeds from the sale of shares of common stock in this offering. Additionally, the selling stockholders may or may not elect to sell all or any portion their shares of common stock.

Read Also: Inflation Slows More Expected To 3% In June, Heightens Expectations For Rate Cuts: Treasury Yields Tumble

Should I Sell My SEZL Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Sezzle ( SEZL ) stock currently has an RSI of 48.90, indicating neutral conditions.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.

SEZL has a 52-week high of $100.00 and a 52-week low of $7.15.

Read Next:

Pfizer Advances Once-Daily Weight-Loss Pill As It Catches Up To Tap The Lucrative Market

Image created using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enanta Pharma Reports Positive Phase 2 Results for Zelicapavir as Treatment of Respiratory Syncytial Virus
Enanta Pharma Reports Positive Phase 2 Results for Zelicapavir as Treatment of Respiratory Syncytial Virus
Dec 9, 2024
10:32 AM EST, 12/09/2024 (MT Newswires) -- Enanta Pharmaceuticals ( ENTA ) reported Monday positive topline results from a phase 2 study evaluating zelicapavir in children with respiratory syncytial virus. The company said zelicapavir showed a significant antiviral effect in young children with respiratory syncytial virus and that the experimental drug reduced viral loads in both hospitalized and non-hospitalized infants...
Ballard Power to Supply Fuel Cell Engines to Stadler for Caltrans; Shares Rise
Ballard Power to Supply Fuel Cell Engines to Stadler for Caltrans; Shares Rise
Dec 9, 2024
10:34 AM EST, 12/09/2024 (MT Newswires) -- Ballard Power Systems ( BLDP ) said Monday it signed a multiyear deal with Stadler US to supply 8 megawatts of FCmove-HD+ fuel cell engines for trains for the California Department of Transportation, or Caltrans. The order supports the department's acquisition of 10 FLIRT H2 passenger trains, with an option for another 19...
New Fortress Completes $1.5 Billion Exchange of Senior Secured Notes
New Fortress Completes $1.5 Billion Exchange of Senior Secured Notes
Dec 9, 2024
10:33 AM EST, 12/09/2024 (MT Newswires) -- New Fortress Energy ( NFE ) said Monday it completed the private exchange of $1.5 billion of new senior secured notes for over two-thirds of its outstanding senior secured notes due 2026 and 2029. The company said the deal is the final step of issuing $2.7 billion of new senior secured notes due...
Pactiv Evergreen to Be Taken Private by Apollo-Backed Novolex in $6.7 Billion All-Cash Deal
Pactiv Evergreen to Be Taken Private by Apollo-Backed Novolex in $6.7 Billion All-Cash Deal
Dec 9, 2024
10:28 AM EST, 12/09/2024 (MT Newswires) -- Pactiv Evergreen ( PTVE ) agreed to be acquired and taken private by Novolex in an all-cash deal worth $6.7 billion, including debt, according to a joint Monday statement. Shareholders of Pactiv Evergreen ( PTVE ) will receive $18 per share in cash, reflecting a 49% premium to the packaging products maker's two-month...
Copyright 2023-2026 - www.financetom.com All Rights Reserved